EBV CAR-T / TCR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV CAR-T / TCR-T Cells, covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma [EARLY_Phase 1]